Global Peptides and Heparin Market Estimated to Exceed US$ 34,000 Mn by 2026-end

Dublin 2, Ireland, 2018-Jun-21 — /EPR Network/ — With a prime focus on peptides and heparin industry, research analysts of Fact. MR has publicized a comprehensive study to its online repository. This in-depth study is headlined as “Peptides and Heparin Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026” which discusses the historic and current scenario of the global market, along with the future prospects it holds for a 10 year assessment period, 2017-2026. For the benefit of the investors of the report, this research focuses on the drivers and restraints anticipated to impact the demand for peptides and heparin in the coming years. Along with these insights, the report provides the readers crucial insights on the strategies implemented by leading companies to remain in the lead of this competitive market.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=378

According to Fact.MR, the global peptide and heparin market is projected to reflect a high single-digit CAGR throughout the forecast period (2017-2026). The market is estimated to reach nearly US$ 35,000 Mn revenues by 2026-end.

4 Key Future Prospects of Peptide and Heparin Market for Forecast Period 2017-2026

1. Hospital pharmacies are expected to remain the dominant distribution channel for peptide and heparin. Revenues from sales of peptide and heparin in hospital pharmacies are anticipated to remain considerably larger than those from retail pharmacies and online pharmacies combined.

2. On the basis of indication, revenues from sales of peptide and heparin for cancer treatment are projected to account for the largest market share by 2026-end. Cardiovascular and metabolic disorder indication will also remain remunerative in the market. Sales of peptide and heparin for central nervous systems indication are expected to register the fastest expansion through 2026.

3. Oral route of administration will remain preferred for peptide and heparin, with revenues estimated to surpass US$ 15,000 Mn by 2026-end. However, sales of peptide and heparin with intravenous route of administration will register a comparatively faster growth through 2026.

4. Liraglutide is expected to remain the most lucrative product in the market, followed by bortezomib and goserelin. Liraglutide sales will exhibit the highest CAGR through 2026. In addition, sales of sodium heparin, lithium heparin and exenatide are projected to register a parallel growth through 2026.

Browse Full Report with TOC- https://www.factmr.com/report/378/peptides-heparin-market

APEJ to Remain Most Remunerative Market for Peptide and Heparin

There has been a growing demand for new oral anticoagulants having better efficacy and safety profiles in Asia-Pacific excluding Japan (APEJ). Side effects related to heparin products, including complications of bleeding and heparin-induced thrombocytopenia has resulted into robust adoption of oral anticoagulants in the region. In addition, rising incidence of cancer, metabolic disorders, and hepatitis, along with advancements in peptide synthesis technology and rapid demand for various peptide therapies in the region are expected to drive the growth in APEJ. APEJ will remain the most remunerative market for peptide and heparin.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

Table of Content:

1. Global Economic Outlook

2. Global Peptide and Heparin Market – Executive Summary

3. Global Peptide and Heparin Market Overview
3.1. Introduction
3.1.1. Global Peptide and Heparin Market Taxonomy
3.1.2. Global Peptide and Heparin Market Definition
3.2. Global Peptide and Heparin Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Peptide and Heparin Market Y-o-Y Growth
3.3. Global Peptide and Heparin Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTLE Analysis
3.7. Product Lifecycle
3.8. List of Distributors
3.9. Key Participants Market Presence (Intensity Map) By Region

4. Global Peptide and Heparin Market Analysis and Forecast 2012-2026 
4.1. Global Peptide and Heparin Market Size and Forecast By Product Type , 2012-2026
4.1.1. Sodium Heparin Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region

Continued….

Buy this Report- https://www.factmr.com/checkout/378/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized  Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/
Get More Industry Insights At: https://www.linkedin.com/company/factmr/